Gene expression profilers and conventional clinical markers to predict distant recurrences for premenopausal breast cancer patients after adjuvant chemotherapy

This publication has 34 references indexed in Scilit:

• Gene expression profiles relate to SS18/SSX fusion type in synovial sarcoma
  International Journal of Cancer, 2005
• Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials
  The Lancet, 2005
• Gene-expression profiles to predict distant metastasis of lymph-node-negative primary breast cancer
  The Lancet, 2005
• A Multigene Assay to Predict Recurrence of Tamoxifen-Treated, Node-Negative Breast Cancer
  New England Journal of Medicine, 2004
• “Good Old” clinical markers have similar power in breast cancer prognosis as microarray gene expression profilers
  European Journal of Cancer, 2004
• ACID: a database for microarray clone information
  Bioinformatics, 2004
• Breast cancer classification and prognosis based on gene expression profiles from a population-based study
  Proceedings of the National Academy of Sciences, 2003
• A Gene-Expression Signature as a Predictor of Survival in Breast Cancer
  New England Journal of Medicine, 2002
• Gene expression profiling predicts clinical outcome of breast cancer
  Nature, 2002
• pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long‐term follow‐up
  Histopathology, 1991